Physician

John Dail Matthews, MD

According to 2025 Medicare claims, John Matthews, MD (NPI: 1659375483) practices ophthalmology in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is MOSES CONE AFFILIATED PHYSICIANS (NPI: 1912270109; TIN: 300554775) and primary practice location at 27401-6003. Matthews is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Matthews' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 13,652 HCPCS/CPT codes, and received $859,880 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 985 prescription claims across 440 beneficiaries totaling $70,769 in drug costs, led by Besivance (Besifloxacin Hcl). Open Payments data shows 2 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $158,842 to $70,769. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$548K$1.1M2015 Medicare payment: $875,719 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $799,325 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $701,112 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $725,221 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $783,573 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $882,806 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $998,410 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,096,261 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,004,773 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $859,880 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201588715,963$875,719
201689416,321$799,325
201789816,749$701,112
201878916,540$725,221
201970315,468$783,573
202061411,333$882,806
202157811,830$998,410
202250510,298$1,096,261
202341411,769$1,004,773
202437213,652$859,880

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$81K$162K2015 Drug cost: $158,842 (USD; Tot_Drug_Cst)2016 Drug cost: $150,247 (USD; Tot_Drug_Cst)2017 Drug cost: $137,596 (USD; Tot_Drug_Cst)2018 Drug cost: $161,841 (USD; Tot_Drug_Cst)2019 Drug cost: $156,980 (USD; Tot_Drug_Cst)2020 Drug cost: $119,914 (USD; Tot_Drug_Cst)2021 Drug cost: $100,135 (USD; Tot_Drug_Cst)2022 Drug cost: $94,325 (USD; Tot_Drug_Cst)2023 Drug cost: $91,542 (USD; Tot_Drug_Cst)2024 Drug cost: $70,769 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154541,221$158,842
20165181,259$150,247
20175661,208$137,596
20185491,337$161,841
20195141,312$156,980
20204771,096$119,914
20214341,026$100,135
2022422977$94,325
20234151,024$91,542
2024440985$70,769

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye328652$109
92014Established patient complete exam of visual system3431,206$89
67028Injection of drug into eye146950$89
92134Imaging of retina3541,235$28
92201Extended exam of the back part of the eye with retinal drawing231308$17

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BesivanceBesifloxacin Hcl1424,302$31,401
ProlensaBromfenac Sodium321,169$12,870
Prednisolone AcetatePrednisolone Acetate1797,474$8,689
Ketorolac TromethamineKetorolac Tromethamine1274,189$3,761
Ciprofloxacin HclCiprofloxacin Hcl2005,847$2,050

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$247Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Dail Matthews, MD?

Tedicare shows public-source Medicare data for John Dail Matthews, MD (NPI 1659375483), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Dail Matthews, MD have ACO affiliation data?

John Dail Matthews, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to John Dail Matthews, MD?

John Dail Matthews, MD is linked to MOSES CONE AFFILIATED PHYSICIANS (billing NPI 1912270109) in the available physician profile data.

Does John Dail Matthews, MD have Open Payments data?

John Dail Matthews, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.